Key result
SIAD appears to underlie early hyponatremia in PAH.
Why the study?
Hyponatremia is associated with mortality in pulmonary arterial hypertension, but its underlying mechanisms remain unclear.
Hyponatremia in early pulmonary arterial hypertension appears to be driven by SIAD rather than right heart failure-induced systemic congestion.
Answers are grounded in this paper and cite their sources.
Hyponatremia mechanisms in PAH may differ from other HF states; leaves open neurohumoral-independent pathways for targeted study.
Because it is associated with mortality, hyponatremia is an important feature of pulmonary arterial hypertension. Its mechanisms remain unclear, although right heart failure resulting from pulmonary arterial hypertension may lead to systemic congestion and arterial underfilling. However, most patients with pulmonary arterial hypertension are clinically euvolemic and have no peripheral edema. Unlike patients with underlying heart disease, neurohumoral activation is not demonstrated in hyponatremic patients with pulmonary arterial hypertension, who show features of congestive heart failure only at later stages in their disease. Here, a case vignette is introduced, and the pathophysiology of hyponatremia in pulmonary arterial hypertension will be discussed. Syndrome of inappropriate antidiuresis (SIAD) appears to underlie hyponatremia in the initial phase of pulmonary arterial hypertension. The mechanisms by which various lung diseases can lead to SIAD remain an enigma.
No takes yet. Share an insight, caveat, or question.
Kang et al. (2020) conducted a review in Pulmonary arterial hypertension with hyponatremia. Hyponatremia was evaluated. Syndrome of inappropriate antidiuresis (SIAD) appears to underlie hyponatremia in the initial phase of pulmonary arterial hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: